Skip to main content
The Maple Markets

Toronto Stock Exchange (TSX) · LS.TO · ISIN CA59633Q1037

Middlefield Healthcare Dividend ETF

No trading activity has been reported for this listing since March 11, 2022. It may be delisted, halted or inactive.

10.94 CAD

March 11, 2022

Sign in to add to portfolio

Middlefield Healthcare Dividend ETF (LS.TO) trades on the Toronto Stock Exchange and operates in the Medical - Healthcare Plans industry. Its market capitalisation is approximately 88.34M CAD. Its ISIN is CA59633Q1037. This page shows the latest available price, the day and 52-week ranges and an interactive chart. Quotes are delayed and are not intended for order execution.

Key facts

Exchange

Toronto Stock Exchange (TSX)

ISIN

CA59633Q1037

Sector

Healthcare

Industry

Medical - Healthcare Plans

Country

CA

Market cap

88.34M CAD

Previous close

10.92 CAD

Day range

10.94 – 11.04

52-week range

10.42 – 12.28

Volume

3

50-day average

10.77 CAD

200-day average

11.27 CAD

Asset type

Etf

Frequently asked

+
What is the LS.TO share price today?
This page shows the latest available Middlefield Healthcare Dividend ETF (LS.TO) price with its change against the prior close. Values are delayed or previous-close, not real-time.
+
Where is Middlefield Healthcare Dividend ETF listed?
Middlefield Healthcare Dividend ETF trades on the Toronto Stock Exchange under the symbol LS.TO, ISIN CA59633Q1037.
+
How large is Middlefield Healthcare Dividend ETF?
Its market capitalisation is approximately 88.34M CAD, based on the latest available price and share count from our data provider.

All Middlefield Healthcare Dividend ETF data comes from exchange and provider feeds for the Toronto Stock Exchange and is published for information, not as investment advice.

Real-time quotes are not licensed; prices are delayed or previous close, so they may lag the market by 15 minutes or a full session. Information only, not for trading. Where a figure is not covered by our licensed sources, the page says so rather than showing a substitute.

We use necessary cookies to run the site and, only with your permission, analytics cookies to understand what readers use. Cookie policy